Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ · Healthcare
Monte Rosa Therapeutics, Inc. Balance Sheet 2023–2025
| Dec 2025 | Dec 2024 | Dec 2023 | |
|---|---|---|---|
| Assets | |||
| Total Assets | 448.7M | 438.7M | 303.8M |
| Cash & Equivalents | 129.9M | 224.3M | 128.1M |
| Liabilities | |||
| Total Liabilities | 215.6M | 215.8M | 124.5M |
| Long-Term Debt | — | — | — |
| Equity | |||
| Shareholders' Equity | 233.1M | 222.9M | 179.3M |
Monte Rosa Therapeutics, Inc. Balance Sheet — FAQ
Monte Rosa Therapeutics, Inc. (GLUE) balance sheet over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see GLUE's balance sheet history?
The chart and table above show Monte Rosa Therapeutics, Inc.'s balance sheet by year and by quarter, including the growth rate.